Kathleen Kemmer

Assistant Professor

  • 582 Citations
  • 6 h-Index
20032017
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 1 Similar Profiles
Breast Neoplasms Medicine & Life Sciences
Random Allocation Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Seminoma Medicine & Life Sciences
Carboplatin Medicine & Life Sciences
Biomarkers Medicine & Life Sciences
Epidermal Growth Factor Receptor Medicine & Life Sciences
Magnetic Resonance Imaging Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2003 2017

  • 582 Citations
  • 6 h-Index
  • 6 Article
35 Citations
Placebos
Breast Neoplasms
Disease-Free Survival
Therapeutics
Recurrence
93 Citations

Adaptive randomization of neratinib in early breast cancer

the I-SPY 2 Investigators, Jul 7 2016, In : New England Journal of Medicine. 375, 1, p. 11-22 12 p.

Research output: Contribution to journalArticle

Random Allocation
Breast Neoplasms
Biomarkers
Hormones
Neoadjuvant Therapy
140 Citations

Adaptive randomization of veliparib-carboplatin treatment in breast cancer

the I-SPY 2 Investigators, Jul 7 2016, In : New England Journal of Medicine. 375, 1, p. 23-34 12 p.

Research output: Contribution to journalArticle

Carboplatin
Random Allocation
Breast Neoplasms
Biomarkers
Triple Negative Breast Neoplasms
22 Citations

Early prediction and evaluation of breast cancer response to neoadjuvant chemotherapy using quantitative DCE-MRI

Tudorica, A., Oh, K. Y., Chui, S. Y. C., Roy, N., Troxell, M. L., Naik, A., Kemmer, K. A., Chen, Y., Holtorf, M. L., Afzal, A., Springer, C. S., Li, X. & Huang, W., Feb 1 2016, In : Translational Oncology. 9, 1, p. 8-17 10 p.

Research output: Contribution to journalArticle

Magnetic Resonance Imaging
Breast Neoplasms
Drug Therapy
Residual Neoplasm
Neoplasms

KIT Mutations are Common in Testicular Seminomas

Kemmer, K., Corless, C. L., Fletcher, J. A., McGreevey, L., Haley, A., Griffith, D., Cummings, O. W., Wait, C., Town, A. & Heinrich, M. C., Jan 2004, In : American Journal of Pathology. 164, 1, p. 305-313 9 p.

Research output: Contribution to journalArticle

Seminoma
Mutation
Dysgerminoma
Stem Cell Factor
Phosphatidylinositol 3-Kinase